NFATC1 and acute respiratory distress syndrome: To determine whether NFATc inhibition alters the release of EVs into the alveolar space, we analyzed BALF EVs from mice pretreated with CNI103 or a VAVAA peptide (Control) and then subjected to LPS-induced ALI or sham injury.